The Nonmydriatic Fundus Camera in Diabetic Retinopathy Screening: A Cost-Effective Study with Evaluation for Future Large-Scale Application

Table 1

Cost of the screening programme, distinguished by phases.

Phases	Human resources	Materials and equipment	Drugs	Total
Phase I	1,056.23	2,112.46	—	3,168.69
Phase II	1,170.98	1,170.39	—	2,341.37
Phase III	3,109.10	—	—	3,109.10
Phase IV	—	—	27,280.65	27,280.65
				Total 35,899.81